Literature DB >> 33762624

Poliovirus-nonsusceptible Vero cell line for the World Health Organization global action plan.

Yuko Okemoto-Nakamura1, Kenji Someya2, Toshiyuki Yamaji1, Kyoko Saito1, Makoto Takeda2, Kentaro Hanada3.   

Abstract

Polio or poliomyelitis is a disabling and life-threatening disease caused by poliovirus (PV). As a consequence of global polio vaccination efforts, wild PV serotypes 2 and 3 have been eradicated around the world, and wild PV serotype 1-transmitted cases have been largely eliminated except for limited regions. However, vaccine-derived PV, pathogenically reverted live PV vaccine strains, has become a serious issue. For the global eradication of polio, the World Health Organization is conducting the third edition of the Global Action Plan, which is requesting stringent control of potentially PV-infected materials. To facilitate the mission, we generated a PV-nonsusceptible Vero cell subline, which may serve as an ideal replacement of standard Vero cells to isolate emerging/re-emerging viruses without the risk of generating PV-infected materials.

Entities:  

Year:  2021        PMID: 33762624     DOI: 10.1038/s41598-021-86050-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  23 in total

1.  Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine.

Authors:  G R Macklin; K M O'Reilly; N C Grassly; W J Edmunds; O Mach; R Santhana Gopala Krishnan; A Voorman; J F Vertefeuille; J Abdelwahab; N Gumede; A Goel; S Sosler; J Sever; A S Bandyopadhyay; M A Pallansch; R Nandy; P Mkanda; O M Diop; R W Sutter
Journal:  Science       Date:  2020-03-19       Impact factor: 47.728

Review 2.  Tissue tropism and species specificity of poliovirus infection.

Authors:  A Nomoto; S Koike; J Aoki
Journal:  Trends Microbiol       Date:  1994-02       Impact factor: 17.079

Review 3.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

Review 5.  New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.

Authors:  Mohammadreza Shaghaghi; Saeed Soleyman-Jahi; Hassan Abolhassani; Reza Yazdani; Gholamreza Azizi; Nima Rezaei; Mohamed-Ridha Barbouche; Mark A McKinlay; Asghar Aghamohammadi
Journal:  Vaccine       Date:  2018-02-23       Impact factor: 3.641

6.  The genome landscape of the african green monkey kidney-derived vero cell line.

Authors:  Naoki Osada; Arihiro Kohara; Toshiyuki Yamaji; Noriko Hirayama; Fumio Kasai; Tsuyoshi Sekizuka; Makoto Kuroda; Kentaro Hanada
Journal:  DNA Res       Date:  2014-09-28       Impact factor: 4.458

7.  Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin.

Authors:  Darryl Falzarano; Emmie de Wit; Cynthia Martellaro; Julie Callison; Vincent J Munster; Heinz Feldmann
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  Novel endogenous simian retroviral integrations in Vero cells: implications for quality control of a human vaccine cell substrate.

Authors:  Chisato Sakuma; Tsuyoshi Sekizuka; Makoto Kuroda; Fumio Kasai; Kyoko Saito; Masaki Ikeda; Toshiyuki Yamaji; Naoki Osada; Kentaro Hanada
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

9.  Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).

Authors:  Camilly P Pires de Mello; George L Drusano; Jaime L Rodriquez; Ajeet Kaushik; Ashley N Brown
Journal:  Viruses       Date:  2018-06-09       Impact factor: 5.048

View more
  1 in total

1.  Novel Antiviral Efficacy of Hedyotis diffusa and Artemisia capillaris Extracts against Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Infection and Immunoregulatory Cytokine Signatures.

Authors:  Zhan Qiu Mao; Noboru Minakawa; Meng Ling Moi
Journal:  Plants (Basel)       Date:  2022-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.